Bringing Clarity to the World of Biomedical Research

At TrialSite News, we cut through the noise to deliver transparent, independent reporting on biomedical and health research. Since 2018, we've resisted both censorship and misinformation—choosing a third path grounded in critical thinking and evolving evidence.

Our original content is backed by two proprietary tools: the TrialSite Evidence Strength Indicator™, rating studies from 0–10 based on rigor and real-world relevance, and the TrialSite Bias Meter™, which flags bias across mainstream, trade, and alternative media. We're reader-supported and free from corporate influence. For just $5/month, you get unlimited access to objective, evidence-based analysis for patients, clinicians, researchers, and policymakers.

Support integrity, clarity, and veracity in biomedical and health-related scientific communications.